45963-480 : Alosetron Hydrochloride 1 mg Oral Tablet


NDC45963-480
Labeler: Actavis Pharma, Inc.
Product Type: Human Prescription Drug
Drug Name:  Alosetron Hydrochloride
Dosage Form: Oral Tablet
Application #: NDA021107
Rev. Date: 


Appearance:


Markings: GX;CT1
Shapes:  Oval
Colors:  Blue
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 45963-480-03: 1 BOTTLE IN 1 CARTON (45963‑480‑03) > 30 TABLET IN 1 BOTTLE

Active Ingredients:

  • Alosetron Hydrochloride

Dosage Strength:

  • 1 mg

Inactive Ingredients:

  • Lactose
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Starch, Corn
  • Hypromelloses
  • Titanium Dioxide
  • Triacetin
  • Indigotindisulfonate Sodium

Pharmaceutical Classes:

  • Serotonin 3 Receptor Antagonists [MoA]
  • Serotonin-3 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 45963-479 Alosetron Hydrochloride .5 mg Oral Tablet by Actavis Pharma, Inc.
  • 0054-0295 Alosetron Hydrochloride .5 mg Oral Tablet by Roxane Laboratories, Inc.
  • 0054-0296 Alosetron Hydrochloride 1 mg Oral Tablet by Roxane Laboratories, Inc.
  • 42291-123 Alosetron Hydrochloride .5 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 42291-124 Alosetron Hydrochloride 1 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 49884-819 Alosetron Hydrochloride .5 mg Oral Tablet by Par Pharmaceutical, Inc.
  • 49884-820 Alosetron Hydrochloride 1 mg Oral Tablet by Par Pharmaceutical, Inc.
  • 65162-248 Alosetron Hydrochloride .5 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals LLC
  • 65162-249 Alosetron Hydrochloride 1 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 45963-480 QR Code

< Prev: 45963-479Next: 45963-500 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 January 2017.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA